Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Danchin

Showing results (21-30 of 432) with videos related to

Pageof 44
Sort By:
Archives of Cardiovascular Diseases|April 9, 2008
From Archives des Maladies du Coeur et des Vaisseaux to Archives of Cardiovascular Diseases: changing format for improved contentNicolas Danchin
Archives of Cardiovascular Diseases|May 29, 2012
Critical appraisal of the 'Consensus statement on care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of an acute coronary syndrome'Nicolas Danchin
La Revue Du Praticien|May 29, 2015
[Coronary artery diseases: a rapid and continuous decline in mortality]Nicolas Danchin
European Heart Journal|April 21, 2006
Should intravenous thrombolysis keep a place in the treatment of acute ST-elevation myocardial infarction?Nicolas Danchin
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 21, 2009
[Optimizing long-term therapy: dawn of a new era]Nicolas Danchin
Lancet (London, England)|July 7, 2009
Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trialNicolas Danchin
Circulation. Cardiovascular Interventions|January 18, 2022
Response by Puymirat and Danchin to Letter Regarding Article, "Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial"Etienne Puymirat, Nicolas Danchin
Circulation. Cardiovascular Interventions|January 18, 2022
Response by Puymirat and Danchin to Letter Regarding Article, "Compared Outcomes of ST-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER MI Trial"Etienne Puymirat, Nicolas Danchin
Revista Espanola De Cardiologia|October 4, 2011
[1980-2010: the three glorious decades of cardiology. A comprehensive and collective effort rewarded by outstanding clinical results]Nicolas Danchin, Etienne Puymirat
Nature Reviews. Cardiology|November 15, 2012
Coronary artery disease. Are β-blockers truly helpful in patients with CAD?Nicolas Danchin, Stéphane Laurent
Pageof 44

Showing results (21-30 of 432) with videos related to

Sort By:
Pageof 44
Archives of Cardiovascular Diseases|April 9, 2008
From Archives des Maladies du Coeur et des Vaisseaux to Archives of Cardiovascular Diseases: changing format for improved contentNicolas Danchin
Archives of Cardiovascular Diseases|May 29, 2012
Critical appraisal of the 'Consensus statement on care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of an acute coronary syndrome'Nicolas Danchin
La Revue Du Praticien|May 29, 2015
[Coronary artery diseases: a rapid and continuous decline in mortality]Nicolas Danchin
European Heart Journal|April 21, 2006
Should intravenous thrombolysis keep a place in the treatment of acute ST-elevation myocardial infarction?Nicolas Danchin
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 21, 2009
[Optimizing long-term therapy: dawn of a new era]Nicolas Danchin
Lancet (London, England)|July 7, 2009
Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trialNicolas Danchin
Circulation. Cardiovascular Interventions|January 18, 2022
Response by Puymirat and Danchin to Letter Regarding Article, "Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial"Etienne Puymirat, Nicolas Danchin
Circulation. Cardiovascular Interventions|January 18, 2022
Response by Puymirat and Danchin to Letter Regarding Article, "Compared Outcomes of ST-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER MI Trial"Etienne Puymirat, Nicolas Danchin
Revista Espanola De Cardiologia|October 4, 2011
[1980-2010: the three glorious decades of cardiology. A comprehensive and collective effort rewarded by outstanding clinical results]Nicolas Danchin, Etienne Puymirat
Nature Reviews. Cardiology|November 15, 2012
Coronary artery disease. Are β-blockers truly helpful in patients with CAD?Nicolas Danchin, Stéphane Laurent
Pageof 44